Remedee Labs

Meylan, France Founded: 2016 • Age: 10 yrs
Endorphin stimulation therapy for pain management is developed.
Request Access

About Remedee Labs

Remedee Labs is a company based in Meylan (France) founded in 2016 by Jacques Husser and David Crouzier.. Remedee Labs has raised $27.83 million across 3 funding rounds from investors including Generali, PAR Technology Corp and Bpifrance. Remedee Labs offers products and services including Novi Rem™, Fibro Rem™, and Remedee Bracelet. Remedee Labs operates in a competitive market with competitors including NeuroMetrix, Sky Medical Technology, Electromedical Technologies, Sure Med Compliance and Neurolytic Healthcare, among others.

  • Headquarter Meylan, France
  • Founders Jacques Husser, David Crouzier
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Remedee Labs
Operational Areas
Healthcare → Health Technology & Digital Health
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $27.83 M (USD)

    in 3 rounds

  • Latest Funding Round
    $12.86 M (USD), Series A

    Dec 06, 2022

  • Investors
    Generali

    & 6 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Remedee Labs

Remedee Labs offers a comprehensive portfolio of products and services, including Novi Rem™, Fibro Rem™, and Remedee Bracelet. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for relieving arthrose pain through neuromodulation

Solution for managing fibromyalgie symptoms via endorphin stimulation

Bracelet that stimulates endorphins to reduce chronic pain

Funding Insights of Remedee Labs

Remedee Labs has successfully raised a total of $27.83M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $12.86 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Series A — $12.9M
  • First Round

    (01 Jun 2016)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2022 Amount Series A - Remedee Labs Valuation Generali , HCVC
Apr, 2019 Amount Series A - Remedee Labs Valuation HCVC
Jun, 2016 Amount Seed - Remedee Labs Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Remedee Labs

Remedee Labs has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Generali, PAR Technology Corp and Bpifrance. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are directed toward hard-tech and full-stack companies by HCVC.
Founded Year Domain Location
-
Founded Year Domain Location
Venture capital fund focused on series A stage hardware, future work, commerce, and digital media companies
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Remedee Labs

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Remedee Labs

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Remedee Labs Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Remedee Labs

Remedee Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroMetrix, Sky Medical Technology, Electromedical Technologies, Sure Med Compliance and Neurolytic Healthcare, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Wearable technology for pain, nerve disease and sleep disorders
domain founded_year HQ Location
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
domain founded_year HQ Location
An electrotherapy device that helps reduce and eliminate chronic or acute pain
domain founded_year HQ Location
Provider of a digital health platform for pain management
domain founded_year HQ Location
Smart medical devices for neurological disorder treatment are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Remedee Labs

When was Remedee Labs founded?

Remedee Labs was founded in 2016.

Where is Remedee Labs located?

Remedee Labs is headquartered in Meylan, France. It is registered at Meylan, Isere, France.

Who is the current CEO of Remedee Labs?

David Crouzier is the current CEO of Remedee Labs. They have also founded this company.

Is Remedee Labs a funded company?

Remedee Labs is a funded company, having raised a total of $27.83M across 3 funding rounds to date. The company's 1st funding round was a Seed of $2.64M, raised on Jun 01, 2016.

What does Remedee Labs do?

Remedee Labs was founded in 2016 in Meylan, France, within the health technology sector. Patented Microelectronic Endorphin Trigger (MEET) technology is utilized to develop therapies for pain management. Ongoing clinical trials address conditions including innocuity, arthrosis, surgical pain, and migraine. Operations focus on advancing non-invasive endorphin-based treatments through research and validation processes.

Who are the top competitors of Remedee Labs?

Remedee Labs's top competitors include Sky Medical Technology, Electromedical Technologies and Sure Med Compliance.

What products or services does Remedee Labs offer?

Remedee Labs offers Novi Rem™, Fibro Rem™, and Remedee Bracelet.

Who are Remedee Labs's investors?

Remedee Labs has 7 investors. Key investors include Generali, PAR Technology Corp, Bpifrance, HCVC, and Habert Dassault Finance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available